CausalSentinel

Protein Dossier — POSTN (Periostin)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Squamous cell lung cancer 0.395 0.109 2.85e-04 Wald ratio 1 cis NA
Lung cancer 0.235 0.0736 0.00141 Wald ratio 1 cis NA
Systolic blood pressure automated reading -0.0284 0.0107 0.00803 Wald ratio 1 cis NA
Lung adenocarcinoma 0.27 0.112 0.0158 Wald ratio 1 cis NA
Diagnoses - main ICD10: I83 Varicose veins of lower extremities -0.221 0.092 0.0164 Wald ratio 1 cis NA
Body mass index (BMI) -0.0248 0.0105 0.0177 Wald ratio 1 cis NA
Rheumatoid arthritis 0.161 0.0701 0.0218 Wald ratio 1 cis NA
Non-cancer illness code self-reported: enlarged prostate -0.232 0.115 0.0427 Wald ratio 1 cis NA
Non-cancer illness code self-reported: mania or bipolar disorder or manic depression 0.306 0.155 0.0488 Wald ratio 1 cis NA
Low grade serous ovarian cancer -0.398 0.207 0.0547 Wald ratio 1 cis NA
Forced expiratory volume in 1-second (FEV1) 0.0171 0.00905 0.0588 Wald ratio 1 cis NA
Diagnoses - main ICD10: I48 Atrial fibrillation and flutter -0.225 0.126 0.0752 Wald ratio 1 cis NA
…and 65 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3457_57_1 Periostin Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

26 association rows across 16 traits (25 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
POSTN protein levels 4e-192 rs117103342 4 GCST90470288 no MR -> candidate analysis
Serum levels of protein POSTN 4e-51 rs117103342 2 GCST90089547 no MR -> candidate analysis
Periostin (analyte X3457.57) levels 1e-31 rs17056197 1 GCST90425776 no MR -> candidate analysis
Height 1e-29 rs12871092 3 GCST90245848 no MR -> candidate analysis
Periostin levels (POSTN.6650.20.3) 2e-28 rs117103342 2 GCST90242226 no MR -> candidate analysis
Smoking initiation 7e-26 rs9576317 4 GCST90243968 no MR -> candidate analysis
Periostin (analyte X6645.53) levels 8e-18 rs12866877 1 GCST90426806 no MR -> candidate analysis
Educational attainment 1e-16 rs17257579 1 GCST90105038 no MR -> candidate analysis
Periostin levels 9e-13 rs73184525 1 GCST90161797 no MR -> candidate analysis
Diastolic blood pressure 7e-12 rs78641506 1 GCST90662909 no MR -> candidate analysis
Externalizing behaviour (multivariate analysis) 9e-12 rs17197978 1 GCST90061435 no MR -> candidate analysis
Smoking initiation (ever regular vs never regular) (MTAG) 3e-11 rs73184528 1 GCST007468 no MR -> candidate analysis
…and 4 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 2541 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
smoking initiation 0.699 common-variant locus no MR -> candidate analysis
Varicose veins 0.57 common-variant locus MR: beta=-0.221, p=0.0164 (cis)
substance abuse 0.555 common-variant locus no MR -> candidate analysis
attention deficit-hyperactivity disorder 0.555 common-variant locus no MR -> candidate analysis
ankylosing spondylitis 0.52 common-variant locus no MR -> candidate analysis
alcohol drinking 0.339 common-variant locus no MR -> candidate analysis
vein disorder 0.32 common-variant locus no MR -> candidate analysis
lymphatic system disorder 0.32 common-variant locus no MR -> candidate analysis
aortic stenosis 0.272 common-variant locus no MR -> candidate analysis
lumbar disc herniation 0.253 common-variant locus no MR -> candidate analysis
palmar fibromatosis 0.253 common-variant locus no MR -> candidate analysis
glomerulonephritis 0.236 common-variant locus no MR -> candidate analysis
diabetes mellitus 0.172 common-variant locus no MR -> candidate analysis
ovarian neoplasm 0.181 common-variant locus no MR -> candidate analysis

Of the 14 rows above, 13 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=3.4e-16, LOEUF=0.828 — LoF-tolerant
GWAS Catalog 67 unique SNPs / 134 rows
ClinVar 196 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance